+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Shield Therapeutics Plc - logo

Shield Therapeutics is a specialty pharmaceutical company focused on the development and commercialisation of late‑stage, hospital‑focused pharmaceuticals which address areas of high unmet medical need. The company’s key products are Feraccru and PT20, one commercially available and one late-stage pharmaceutical for the treatment of iron deficiency anaemia and systemic phosphate accumulation. The company also develops PT30 and PT40 intravenous iron formulations. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.

Intravenous (IV) Iron Drugs - Global Strategic Business Report - Product Thumbnail Image

Intravenous (IV) Iron Drugs - Global Strategic Business Report

  • Report
  • February 2024
  • 354 Pages
  • Global
From
Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029 - Product Thumbnail Image

Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029

  • Report
  • February 2024
  • 126 Pages
  • Global
From
Iron Drugs - Global Strategic Business Report - Product Thumbnail Image

Iron Drugs - Global Strategic Business Report

  • Report
  • February 2024
  • 187 Pages
  • Global
From
From
Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H2 2019 - Product Thumbnail Image

Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 70 Pages
  • Global
From
Global Iron Drugs Market 2023-2027 - Product Thumbnail Image

Global Iron Drugs Market 2023-2027

  • Report
  • May 2023
  • 159 Pages
  • Global
From
From
From
From
From
From
Ulcerative Colitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ulcerative Colitis Therapeutics - Global Strategic Business Report

  • Report
  • February 2024
  • 181 Pages
  • Global
From
Global Chronic Kidney Disease (CKD) Drugs Market 2024-2028 - Product Thumbnail Image

Global Chronic Kidney Disease (CKD) Drugs Market 2024-2028

  • Report
  • November 2023
  • 184 Pages
  • Global
From
Hyperphosphatemia - Pipeline Review, H1 2020 - Product Thumbnail Image

Hyperphosphatemia - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 80 Pages
  • Global
From
From
Loading Indicator